SHAREHOLDER ALERT: Weiss Law Investigates Infrastructure and Zymergen Inc.

NEW YORK, July 25, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Zymergen Inc. ("Zymergen" or the "Company") (NASDAQ: ZY), connected with the proposed acquisition of the Company by Ginkgo Bioworks Holdings, Inc. ("Ginkgo") (NYSE: DNA). Under the terms of the merger agreement, the Company's shareholders will receive 0.9179 shares of Ginkgo common stock for each Zymergen share owned, representing implied per-share merger consideration of approximately $2.68 based upon Ginkgo's July 22, 2022 closing price of $2.92. 

Read more at prnewswire.com